Focus on the ADC field, promote technology iteration and product development, and establish technology and product advantages
Medilink Therapeutics focuses on developing internationally competitive drug conjugates, as well as the latest generation of technologies and products with independent intellectual property rights and better therapeutic windows, to serve the unmet clinical needs. It strives to continuously upgrade technologies, establish diverse technology platforms for drug conjugates, and expand into new disease areas to serve global patients.
Learn moreEstablished by a senior ADC team, covering the entire ADC process
With the continuous development of the company, we have won the favor of many partners
